Frederick Schmid
Sales & Marketing chez Roche Laboratories, Inc.
Provenance du réseau au premier degré de Frederick Schmid
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ.
8
| Subsidiary | Medical Distributors | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Frederick Schmid via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director of Finance/CFO General Counsel | |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chairman | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Vytal, Inc.
 Vytal, Inc. Drugstore ChainsRetail Trade Vytal, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA. | Drugstore Chains | Corporate Officer/Principal | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lycia Therapeutics, Inc.
 Lycia Therapeutics, Inc. BiotechnologyHealth Technology Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
dpa Deutsche Presse-Agentur GmbH
 dpa Deutsche Presse-Agentur GmbH Internet Software/ServicesTechnology Services dpa Deutsche Presse-Agentur GmbH publishes on-line news. It develops and produces multimedia news products for the Web, mobile portal, and print applications, as well as engages in managing mobile services for media companies, providing cross media services for newspapers, international still graphics, and offers picture agency services. The company was founded in 1949 and is headquartered in Hamburg, Germany. | Internet Software/Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
AIDS Healthcare Foundation
 AIDS Healthcare Foundation Investment Trusts/Mutual FundsMiscellaneous AIDS Healthcare Foundation is a non-profit organization which engages in the provision of medicine and advocacy programs for HIV/AIDS. The firm offers HIV and STD testing, thrift store, dental clinic, and healthcare center services. The company was founded by Michael Weinstein in 1987 and is headquartered in Los Angeles, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
FORM Life Ventures
 FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | Investment Managers | Consultant / Advisor | |
| ATAI LIFE SCIENCES N.V. | Pharmaceuticals: Major | Director/Board Member | |
| Bentley University | College/University | Masters Business Admin | |
| University of Rhode Island | College/University | Undergraduate Degree | |
AverStar, Inc.
 AverStar, Inc. Packaged SoftwareTechnology Services AverStar, Inc. is a company based in Burlington, MA that specializes in [description not provided]. AverStar, Inc. has subsidiaries in the United States. AverStar was acquired by The Titan Corp. on June 27, 2000 for $140 million. | Packaged Software | Director of Finance/CFO | |
| Brown University | College/University | Graduate Degree | |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Geneva | College/University | Doctorate Degree | |
BaroSense, Inc.
 BaroSense, Inc. Medical SpecialtiesHealth Technology BaroSense Inc. operates as a medical device company that focuses on the research and development of minimally invasive medical devices for the treatment of obesity. The company was founded by Richard S. Stack and William N. Starling, Jr. in 2001 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
Cytogel Pharma LLC
 Cytogel Pharma LLC BiotechnologyHealth Technology Cytogel Pharma LLC develops bio-pharmaceutical products. It offers novel analgesic products, useful polymer and hydrogel drug delivery platform technologies. The company was founded in 2002 and is headquartered in Darien, CT. | Biotechnology | Director/Board Member | |
| RECCE PHARMACEUTICALS LTD | Pharmaceuticals: Major | Director/Board Member | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Investment Committee Member | |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member | |
| Trinity University | College/University | Undergraduate Degree | |
| New York University | College/University | Graduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin | |
Emerald BioAgriculture Corp.
 Emerald BioAgriculture Corp. Agricultural Commodities/MillingProcess Industries Emerald BioAgriculture Corp. develops, manufactures, and markets crop protection products. The firm provides applications from modern biology to crop yields that combat disease and fight pests. It also provides agricultural products and consultant services. The company was founded in 1994 and is headquartered in Okemos, MI. | Agricultural Commodities/Milling | Director/Board Member | |
| BIOSYNTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Gentis, Inc.
 Gentis, Inc. Medical SpecialtiesHealth Technology Gentis, Inc. engages in the development and testing technologies for the minimally invasive treatments. The company was founded by Charles Cohen and Paul Ducheyne in 2000 and is headquartered in Wayne, PA. | Medical Specialties | Director/Board Member | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 41 |
| Allemagne | 3 |
| Royaume-Uni | 3 |
| Canada | 3 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 8 |
| Finance | 5 |
| Technology Services | 4 |
| Distribution Services | 3 |
Opérationnelle
| Director/Board Member | 102 |
| Corporate Officer/Principal | 44 |
| President | 25 |
| Independent Dir/Board Member | 25 |
| Director of Finance/CFO | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Alan Dunton | 34 |
| Herb H. Hooper | 27 |
| Jane Henderson | 25 |
| Laurent Fischer | 23 |
| Eric Linsley | 21 |
| Myron Holubiak | 21 |
| Robert G. Savage | 19 |
| Stephen G. Sudovar | 12 |
| Amar P. Singh | 11 |
| Thomas Lategan | 8 |
| Samuel K. Ackerman | 7 |
| Peyton J. Marshall | 7 |
| Jules S. Jacob | 7 |
| Tammy Reilly | 6 |
| Robert B. Pelletier | 6 |
- Bourse
- Insiders
- Frederick Schmid
- Connexions Sociétés
